Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer

Journal of Surgical Oncology

Volumn 100, Issue 5, 2009, Pages 396-400

  Wang, Likui ^a   Liu, Qun ^a   Zhou, Wanqing ^a   Shao, Haifeng ^a   Li, Fangqiu ^a   Li, Xiaojun ^a  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

Gastric cancer; Immunohistochemistry; Mcl 1; Overall survival; Prognosis

Indexed keywords

PROTEIN MCL 1;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER INVASION; CANCER SURGERY; CANCER TISSUE; COMPARATIVE STUDY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH MUCOSA; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM INVASIVENESS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 70349246434     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21344     Document Type: Article

References (26)

1. Roder DM: The epidemiology of gastric cancer. Gastric Cancer 2002;5:5-11.
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Fuchs CS, Mayer RJ: Gastric carcinoma. N Engl J Med 1995; 333:32-41.
4. Kozopas KM, Yang T, Buchan HL, et al.: Mcl1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl2. Proc Natl Acad Sci USA 1993;90:3516-3520. (Pubitemid 23111397)
5. Willis SN, Chen L, Dewson G, et al.: Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005;19:1294-1305. (Pubitemid 41003019)
6. Chen L, Willis SN, Wei A, et al.: Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005;17:393-403. (Pubitemid 40193310)
7. Akgul C, Turner PC, White MR, et al.: Functional analysis of the human MCL-1 gene. Cell Mol Life Sci 2000;57:684-691. (Pubitemid 30311437)
8. Sieghart W, Losert D, Strommer S, et al.: Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy. J Hepatol 2006;44:151-157. (Pubitemid 41772529)
9. Schulze-Bergkamen H, Ehrenberg R, Hickmann L, et al.: Bcl-x (L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells. World J Gastroenterol 2008;14:3829-3840.
10. Pepper C, Lin TT, Pratt G, et al.: Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood 2008;112:3807-3817.
11. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 2000;88:921-932.
12. Vidal O, Soriano-Izquierdo A, Pera M, et al.: Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: Results of a study assessing a panel of angiogenic markers. J Gastrointest Surg 2008;12: 1005-1014.
13. Galizia G, Lieto E, Orditura M, et al.: Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg 2007;31:1458-1468. (Pubitemid 46945355)
14. Sumiyoshi Y, Kakeji Y, Egashira A, et al.: Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 2006;12: 5112-5117. (Pubitemid 44453338)
15. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
16. Adams JM, Cory S: The Bcl-2 protein family: Arbiters of cell survival. Science 1998;281:1322-1326. (Pubitemid 28406819)
17. Huang DC, Adams JM, Cory S: The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. EMBO J 1998;17:1029-1039.
18. Reed JC, Miyashita T, Takayama S, et al.: BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 1996;60:23-32. (Pubitemid 26047917)
19. Del Bufalo D, Biroccio A, Leonetti C, et al.: Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J 1997;11:947-953. (Pubitemid 27425896)
20. Biroccio A, Candiloro A, Mottolese M, et al.: Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J 2000;14:652-660. (Pubitemid 30198564)
21. Wuilleme-Toumi S, Robillard N, Gomez P, et al.: Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival. Leukemia 2005;19:1248-1252. (Pubitemid 40946011)
22. Backus HH, van Riel JM, van Groeningen CJ, et al.: Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer. Ann Oncol 2001;12:779-785. (Pubitemid 32655086)
23. Taniai M, Grambihler A, Higuchi H, et al.: Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res 2004;64:3517-3524. (Pubitemid 38657926)
24. Nguyen M, Marcellus RC, Roulston A, et al.: Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL -1-mediated resistance to apoptosis. Proc Natl Acad Sci USA 2007; 104:19512-19517.
25. Thallinger C, Wolschek MF, Wacheck V, et al.: Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model. J Invest Dermatol 2003;120:1081-1086. (Pubitemid 36702921)
26. Wei SH, Dong K, Lin F, et al.: Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. Cancer Chemother Pharmacol 2008;62:1055-1064.